Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group (Q44706813)
Jump to navigation
Jump to search
scientific article published on 17 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group |
scientific article published on 17 June 2013 |
Statements
1 reference
Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group (English)
1 reference
1 reference
Martin Schrappe
1 reference
Gabriele Escherich
1 reference
Arend von Stackelberg
1 reference
Thomas Klingebiel
1 reference
Renate Panzer-Grümayer
1 reference
Arndt Borkhardt
1 reference
Günter Henze
1 reference
Cornelia Eckert
1 reference
Johann Hitzler
1 reference
Christina Peters
1 reference
Karlheinz Seeger
1 reference
Nikola Hagedorn
1 reference
Georg Mann
1 reference
André Schrauder
1 reference
Lucie Sramkova
1 reference
17 June 2013
1 reference
1 reference
31
1 reference
21
1 reference
2736-2742
1 reference
Identifiers
1 reference
1 reference